Preoperative Hemoglobin and Acute Kidney Injury in Emergency Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorSamsun University
About this trial
Optimization of hemoglobin levels for organ perfusion is essential, especially in critically ill patients. Although anemia is associated with severe organ failure, especially in coronary artery disease, the effects of blood transfusion or various interventions to increase hemoglobin levels on outcomes continue to be debated. The effects of hemoglobin levels in emergency surgery patients on the development of postoperative AKI have been investigated in a small number of studies in the literature, and clear results have not yet been reported. This study was designed to evaluate the effect of hemoglobin levels on the development of AKI after adjustment for known predictive factors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing emergency non-cardiac surgery
Disqualifiers
Known renal failure
Need for reoperation within 48 hours postoperatively
Exit status within 48 hours postoperatively
Known hematological disease
Trial population
Patients undergoing emergency non-cardiac surgery
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Observational
Other interventionPostoperative acute kidney injury and hemoglobin level relationship observation
Treatment groups
420 Participants
are divided into 2 treatment groupsGroup A: Group AKI1 intervention
Group B: Group non-AKI1 intervention
Trial outcomes
Primary outcomes
1
Acute renal failure.
The effect of hemoglobin level before emergency surgery on the development of postoperative acute renal failure.
Time frame
72 hoursSecondary outcomes
1
Hospital days
The effect of hemoglobin level before emergency surgery on the hospital days
Time frame
1 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov